This observational trial will examine the efficacy and safety of Mircera for renal anemia in participants with stage III-IV CKD in daily clinical practice. Mircera will be prescribed by treating physician and followed for approximately 36 months.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Percentage of Participants With Hemoglobin (Hb) Value Within the Target Range (110 to 120 Grams Per Liter [g/L]) at Baseline
Timeframe: Baseline
Percentage of Participants With Hb Value Within the Target Range (110 to 120 g/L) at Months 1-3
Timeframe: At Months 1-3
Percentage of Participants With Hb Value Within the Target Range (110 to 120 g/L) at Months 4-6
Timeframe: At Months 4-6
Percentage of Participants With Hb Value Within the Target Range (110 to 120 g/L) at Months 7-9
Timeframe: At Months 7-9
Percentage of Participants With Hb Value Within the Target Range (110 to 120 g/L) at Months 10-12
Timeframe: At Months 10-12
Percentage of Participants With Hb Value Within the Target Range (110 to 120 g/L) at Months 13-15
Timeframe: At Months 13-15
Percentage of Participants With Hb Value Within the Target Range (110 to 120 g/L) at Months 16-18
Timeframe: At Months 16-18
Percentage of Participants With Hb Value Within the Target Range (110 to 120 g/L) at Months 19-21
Timeframe: At Months 19-21
Percentage of Participants With Hb Value Within the Target Range (110 to 120 g/L) After 21 Months up to 36 Months
Timeframe: After 21 Months up to 36 Months
Percentage of Participants With Hemoglobin (Hb) Value Within the Target Range (100 to 130 g/L) at Baseline
Timeframe: At Baseline
Percentage of Participants With Hb Value Within the Target Range (100 to 130 g/L) at Months 1-3
Timeframe: At Months 1-3
Percentage of Participants With Hb Value Within the Target Range (100 to 130 g/L) at Months 4-6
Timeframe: At Months 4-6
Percentage of Participants With Hb Value Within the Target Range (100 to 130 g/L) at Months 7-9
Timeframe: At Months 7-9
Percentage of Participants With Hb Value Within the Target Range (100 to 130 g/L) at Months 10-12
Timeframe: At Months 10-12
Percentage of Participants With Hb Value Within the Target Range (100 to 130 g/L) at Months 13-15
Timeframe: At Months 13-15
Percentage of Participants With Hb Value Within the Target Range (100 to 130 g/L) at Months 16-18
Timeframe: At Months 16-18
Percentage of Participants With Hb Value Within the Target Range (100 to 130 g/L) at Months 19-21
Timeframe: At Months 19-21
Percentage of Participants With Hb Value Within the Target Range (100 to 130 g/L) After 21 Months up to 36 Months
Timeframe: After 21 Months up to 36 Months